Network Health Intervention for Adolescents Leaving Acute Psychiatric Care

Status Terminated

Clinical Trial Summary

The purpose of this pilot study is to refine and then assess the feasibility, acceptability, and target engagement of Acute Youth Connect - a network health intervention for adolescents leaving acute psychiatric care with suicide-related concerns.

Clinical Trial Description

This pilot study includes only one arm of subjects, all of whom will receive Acute Youth Connect, in addition to treatment as usual. The Acute Youth Connect treatment protocol lasts for 12 weeks following discharge, for a total intervention period of roughly 13 weeks including pre-discharge consent and nomination of supports. Patients will be assessed at baseline, mid-intervention, immediately post-intervention, and 12 weeks following the scheduled intervention completion. Feedback from the first 5-10 patients will be used to modify the treatment protocol to improve patient acceptability. All remaining patients will receive this refined treatment protocol. At the time of registration, the Acute Youth Connect treatment protocol is as follows. Adolescents in acute psychiatric care (partial hospitalization) will be screened for eligibility approximately one week before discharge. After patient assent and parental consent are received, the patient and a parent/caregiver will together nominate 3-4 trusted adults in the patient's life to serve as a post-discharge support team. The nominees will then be contacted, consented, and receive a 45-90 minute training on how to provide social support to the patient. Each adult support will also receive weekly (3-15 minute) check in calls from study staff to monitor progress and resolve any concerns related to the patient's progress. In addition, each patient will attend 3 interactive sessions with a study interventionist, and will be encouraged to bring an adult from their support team to participate as well. These sessions will be evenly spaced throughout the post-discharge intervention period. Adolescents will receive weekly reflection-prompting text messages to practice skills taught in the interactive sessions. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05340296
Study type	Interventional
Source	University of Rochester
Contact
Status	Terminated
Phase	N/A
Start date	July 1, 2022
Completion date	October 6, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03185026` - Psychoeducation for Suicidal Behavior	N/A
Recruiting	`NCT05609487` - Evaluation of the Safety Plan to Prevent Suicidal Reiteration	N/A
Recruiting	`NCT06322199` - Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
Completed	`NCT03134885` - Evaluation of a Regional Post-discharge Monitoring System for Suicide Attempters
Completed	`NCT01535482` - Cognitive Therapy for Suicidal Older Men	N/A
Completed	`NCT01118208` - Blister Packaging Medication to Increase Treatment Adherence and Clinical Response	N/A
Completed	`NCT01360736` - A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL)	N/A
Completed	`NCT05580757` - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Not yet recruiting	`NCT05427734` - Treating Drivers of Suicide Using Jaspr Health	N/A
Recruiting	`NCT06406972` - Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care
Recruiting	`NCT05537376` - A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness	N/A
Completed	`NCT03227991` - Safety Planning Intervention to Reduce Short Term Risk	N/A
Recruiting	`NCT04962373` - Brief Admission for Adolescents Who Self-harm
Completed	`NCT02985047` - Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide	N/A
Enrolling by invitation	`NCT06060535` - Implementation of Suicide Risk Models in Health Systems	N/A
Recruiting	`NCT04994873` - Skills to Enhance Positivity in Suicidal Youth	N/A
Recruiting	`NCT04592809` - Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents	Phase 3
Completed	`NCT01176929` - Randomized Controlled and Prospective Trial of a Cohort of People Who Made a Suicide Attempt	N/A
Completed	`NCT00558805` - Family Intervention for Suicidal Youth: Emergency Care	Phase 2
Recruiting	`NCT05390918` - Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.